LASIK, PRK, and EVO ICL are not interchangeable

Vision correction can feel like one big category when you are searching online. LASIK gets most of the attention. PRK often shows up as the alternative that people did not know they should compare. EVO ICL may appear once people start reading about higher prescriptions, thin corneas, or alternatives to laser surgery.

But these procedures are not three versions of the same idea.

Amjad Khokhar, M.D., F.A.A.O., from Houston LASIK & Eye, explains that refractive surgery is less about choosing the name people recognize and more about understanding what a patient’s eyes can safely support. Two people may have similar prescriptions on paper and still receive different recommendations after their corneas, tear film, eye health, and lifestyle are reviewed.

That is why a good consultation should feel less like picking from a menu and more like narrowing down what actually fits.

Each option solves the vision problem differently

LASIK and PRK are both laser vision correction procedures. They reshape the cornea, which is the clear front surface of the eye, so light can focus more accurately. The difference is how the laser reaches the tissue being treated.

With LASIK, a flap is made in the cornea and lifted before the laser reshapes tissue underneath. After the laser portion is complete, the flap is placed back into position. The FDA describes LASIK as a procedure that changes the cornea’s focusing power through precise laser removal of corneal tissue [1]. For many candidates, the attraction is practical: early recovery is often one of the points discussed during candidacy planning.

PRK uses a related laser approach, but it does not involve creating a LASIK flap. The FDA explains that PRK exposes the corneal layer differently: the top layer, called the epithelium, is removed so the laser can treat the tissue underneath [1]. That surface layer then heals over time.

That difference can matter for people trying to plan around work, driving, childcare, or a busy week. PRK can involve a different early healing experience than LASIK, so recovery timing and comfort should be part of the consultation, especially when a flap-based procedure is not the best fit.

EVO ICL is a different category altogether. It does not reshape the cornea with a laser. The FDA describes EVO ICL as an artificial lens implanted inside the eye to correct nearsightedness, with a toric version used for nearsighted patients who also have astigmatism [3]. The natural lens stays in place.

So the real comparison starts here: is the eye better suited for a flap-based laser procedure, a surface laser procedure, or a lens-based option? That answer is not obvious from a prescription alone.

Corneal thickness can change the entire recommendation

Most people do not think much about corneal thickness until they start looking into vision correction. Then it can suddenly become one of the most important measurements in the room.

Laser vision correction reshapes the cornea by removing a precise amount of tissue. With LASIK, the flap also factors into the planning. The surgeon has to consider not just whether the prescription can be treated, but whether enough corneal structure will remain afterward.

This is why a consultation should include more than reading letters on a chart. The FDA’s LASIK checklist tells patients to consider several candidacy factors, including whether their prescription has been stable, whether they have thin corneas, whether their pupils are large in dim conditions, and whether they have dry eyes [2].

PRK may be discussed when corneal thickness is a concern because it avoids creating a flap. That does not make it a universal answer. It still requires careful measurements and still changes the cornea. But in certain cases, avoiding the flap step can make the treatment plan more appropriate.

EVO ICL may come into the discussion when the prescription is high, the cornea is thin, or the amount of laser reshaping needed would be less ideal. Since it corrects vision with a lens rather than by removing corneal tissue, it can open a different path for some patients.

A recommendation should come after corneal mapping, tear-film review, and a candidacy conversation. The details are not extra. They are the reason one option may make more sense than another.

Dry eye, contact lens habits, and screen time all matter

People often treat refractive surgery like a numbers problem. Nearsightedness, farsightedness, astigmatism, done. Real eyes are a little more complicated.

Dry eye is a good example. The FDA checklist specifically asks patients to consider tear production and notes that dry eye symptoms can worsen or develop after LASIK [2]. That does not mean everyone with dryness is ruled out. It does mean dryness should be taken seriously before surgery is scheduled.

This is especially relevant for people who are already frustrated with contacts. Some patients want vision correction because contacts are inconvenient. Others want it because their lenses feel dry, scratchy, or intolerable by the end of the day. Those are different stories, even if the prescription looks similar.

Screen time can add to the picture. A person who spends hours on a laptop may notice fluctuating vision, burning, or tired eyes late in the day. That may not be a prescription issue alone. It may point to tear-film instability or an ocular surface problem that needs attention before any refractive plan is finalized.

Lifestyle matters here, but not in a vague inspirational way. A nurse working long shifts, a parent juggling school drop-offs, a runner training outdoors, and a software worker staring at screens all use their eyes differently. Recovery timing, comfort, night vision concerns, dryness, and follow-up schedules can all affect which procedure feels realistic.

A useful consultation should make room for those everyday details. The goal is not just to get someone through surgery. It is to choose a plan that makes sense for how that person actually lives.

The best choice is usually the one your exam supports

It is normal to come into a consultation with a favorite. LASIK has name recognition. PRK has a long history. EVO ICL can sound promising for people who have been told that laser surgery may not be ideal.

Still, the better question is not “Which one is best?” It is “Which one fits my eyes, my risks, and my goals?”

A proper evaluation should look at prescription stability, corneal shape, corneal thickness, tear film, pupil size, age, medical history, and visual expectations. It should also include a plain discussion of trade-offs. LASIK may offer a convenient recovery profile for many good candidates. PRK may be considered when avoiding a flap is useful. EVO ICL may be an option for certain nearsighted patients, including those whose corneas or prescriptions make corneal laser correction less suitable [1,3].

None of these procedures should be presented as interchangeable. They solve similar everyday frustrations, such as glasses fogging, contacts drying out, or distance vision feeling dependent on lenses, but they do it through different surgical pathways.

For readers in Greater Houston, the uploaded practice facts describe a refractive evaluation model that includes corneal laser options, EVO ICL, dry eye optimization, and diagnostic screening for patients with thin corneas, higher prescriptions, or ocular surface concerns. That kind of range matters because the most useful answer may not be the procedure someone expected when they started searching.

The bottom line is simple: LASIK, PRK, and EVO ICL can all reduce dependence on glasses or contacts for the right candidate. They are not interchangeable, which is why the decision should start with measurements before anyone settles on a procedure name.

References: [1] U.S. Food and Drug Administration. (2021). What is LASIK? Content current as of January 15, 2021. [2] U.S. Food and Drug Administration. (2018). LASIK surgery checklist. Content current as of July 11, 2018. [3] U.S. Food and Drug Administration. (2022). EVO/EVO+ Visian Implantable Collamer Lens – P030016/S035. Content current as of April 18, 2022.